Conditions improved by mesenchymal stem cells.
Mesenchymal stem cells (MSCs) have demonstrated therapeutic potential across a wide range of conditions in peer-reviewed clinical research. Below is a summary of conditions where MSC therapy has shown measurable improvement in published studies.
The conditions listed below reflect published clinical research on mesenchymal stem cell therapy. Individual results may vary. These therapies are investigational and have not been approved by the FDA to treat, cure, or prevent any disease.
Osteoarticular Disease & Pain
Cardiovascular Diseases
Pulmonary Diseases
Autoimmune & Allergic Diseases
Neurodegenerative Diseases
Perinatal Neurological Disorders
Liver Diseases
Inflammatory Bowel Disease
Metabolic & Renal Conditions
Stroke
Injuries
Central Nervous System Injuries
Graft-Versus-Host Disease
Infertility
Aging & Frailty
Skin Disorders & Alopecia
Extracellular Vesicles (EVs)
Why mesenchymal stem cells have such broad therapeutic potential.
Mesenchymal stem cells (MSCs) are multipotent stromal cells capable of differentiating into a variety of cell types, including osteoblasts, chondrocytes, myocytes, and adipocytes. Sourced from Wharton's Jelly of umbilical cord tissue, they possess potent immunomodulatory, anti-inflammatory, and regenerative properties.
MSCs exert their therapeutic effects through multiple mechanisms: direct cell replacement, secretion of bioactive molecules (the paracrine effect), modulation of the immune system, and reduction of fibrosis and apoptosis. This is why their application spans such diverse medical categories.
Published research from institutions worldwide, including trials registered on ClinicalTrials.gov, has documented measurable improvements across the conditions listed above. The evidence base continues to grow as clinical trials progress from Phase I safety studies through Phase III efficacy trials.
Immunomodulation
MSCs regulate immune response by suppressing overactive T-cells, B-cells, and natural killer cells, calming autoimmune attacks without broad immunosuppression.
Tissue Regeneration
MSCs differentiate into the specialized cells needed at injury sites, cartilage, bone, cardiac muscle, neural tissue, supporting the body's natural repair processes.
Paracrine Signaling
MSCs release growth factors, cytokines, and extracellular vesicles that signal surrounding cells to reduce inflammation, prevent cell death, and stimulate regeneration.
Anti-Fibrotic Action
MSCs inhibit excessive scar tissue formation in organs like the liver, lungs, and heart, preserving organ function and allowing healthy tissue to rebuild.
See if you're a candidate.
The medical team reviews each application individually to determine candidacy based on your specific condition, medical history, and treatment goals.
Apply for Consultation